Zelnorm, manufactured by Novartis Pharmaceutical Company, has been linked to many serious, life-threatening side effects such as heart attacks, strokes, and gastrointestinal problems including ischemic colitis.
Zelnorm, a popular prescription medication used to treat Irritable Bowel Syndrome (IBS), has been removed from the market due to serious and potentially life threatening problems.
What is the problem with Zelnorm?
Zelnorm is a prescription medication used to treat Irritable Bowel Syndrome (IBS). It was approved by the FDA in July 2002 for IBS and constipation. Before its removal from the market, Zelnorm was one of the top 200 most prescribed brand-name medications in the United States. In March 2007, the FDA concluded that the benefits of Zelnorm no longer out weighed the risks. The FDA requested that sales of Zelnorm be halted as a result of controlled clinical trials of the drug showing an increased risk of serious cardiovascular adverse events (e.g., angina, heart attacks, and strokes) associated with use of Zelnorm. In addition to serious cardiovascular injuries, there is also a potential link between Zelnorm and gastrointestinal injuries such as Intestinal Ischemia, Colonic Ischemia, Ischemic Colitis, Dead Bowel, Ulcerative Colitis and Chron’s Disease.
Side Effects of Zelnorm
There are a variety of side effects associated with Zelnorm. Our firm is pursing the following types of serious, life-threatening side effects:
- Ischemic Colitis (acute or chronic)
- Intestinal Ischemia and/or Colonic Ischemia
- Heart Attack
- Angina Pectoris
- Dead Bowel
- Ulcerative Colitis
- Chron’s Disease
- Serious Cardiovascular Injuries
- Serious Gastrointestinal Injuries